Tactile Systems Technology Inc (TCMD) valuation
Tactile Systems Technology P/E ratio history
Tactile Systems Technology trades at 21.5 times its earnings over the last twelve months and 17.6 times the earnings analysts expect over the next twelve. At its last 6 fiscal year ends its P/E ranged from 11.6 (year to Dec 2023) to 134.0 (year to Dec 2018), with a median of 66.0.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $29.00 | $0.82 | 35.4 | 30.1 |
| Dec 31, 2024 | $17.13 | $0.70 | 24.5 | — |
| Dec 31, 2023 | $14.30 | $1.23 | 11.6 | — |
| Dec 31, 2022 | $11.48 | -$0.89 | n/m | — |
| Dec 31, 2021 | $19.03 | -$0.60 | n/m | 26.6 |
| Dec 31, 2020 | $44.94 | — | n/m | — |
| Dec 31, 2019 | $67.51 | $0.56 | 120.6 | — |
| Dec 31, 2018 | $45.55 | $0.34 | 134.0 | — |
| Dec 31, 2017 | $28.98 | $0.30 | 96.6 | — |
| Dec 31, 2016 | $16.41 | — | n/m | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Tactile Systems Technology valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Tactile Systems TechnologyTCMD | $520M | 21.5 | 17.6 | 1.5 |
| Puma BiotechnologyPBYI | $531M | 20.1 | — | 2.3 |
| ArvinasARVN | $507M | 32.8 | — | 1.6 |
| Sight SciencesSGHT | $507M | — | — | 6.1 |
| Nrc HealthNRC | $537M | 99.3 | 23.0 | 3.8 |
| Bright Minds BiosciencesDRUG | $539M | — | — | — |
| Diamedica TherapeuticsDMAC | $498M | — | — | — |
| Sbc Medical GroupSBC | $543M | 11.0 | 10.6 | 3.1 |
| AngiodynamicsANGO | $496M | — | — | 1.5 |
| Peer median | 26.4 | 16.8 | 2.7 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: TCMD financials · TCMD returns
No forecast, no recommendation. This page describes Tactile Systems Technology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.